DK496687D0 - Anvendelse af medetomidin til fremstilling af laegemiddel til brug ved behandling af angstsygdomme - Google Patents

Anvendelse af medetomidin til fremstilling af laegemiddel til brug ved behandling af angstsygdomme

Info

Publication number
DK496687D0
DK496687D0 DK496687A DK496687A DK496687D0 DK 496687 D0 DK496687 D0 DK 496687D0 DK 496687 A DK496687 A DK 496687A DK 496687 A DK496687 A DK 496687A DK 496687 D0 DK496687 D0 DK 496687D0
Authority
DK
Denmark
Prior art keywords
treatment
medetomidin
diseases
preparation
application
Prior art date
Application number
DK496687A
Other languages
English (en)
Other versions
DK496687A (da
DK175040B1 (da
Inventor
Risto Lammintausta
Raimo Virtanen
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmos Oy filed Critical Farmos Oy
Publication of DK496687D0 publication Critical patent/DK496687D0/da
Publication of DK496687A publication Critical patent/DK496687A/da
Application granted granted Critical
Publication of DK175040B1 publication Critical patent/DK175040B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DK198704966A 1986-11-11 1987-09-22 Anvendelse af medetomidin til fremstilling af lægemiddel til brug ved behandling af angstsygdomme DK175040B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI864570 1986-11-11
FI864570A FI864570A0 (fi) 1986-11-11 1986-11-11 Terapeutiskt anvaendbar foerening.

Publications (3)

Publication Number Publication Date
DK496687D0 true DK496687D0 (da) 1987-09-22
DK496687A DK496687A (da) 1988-05-12
DK175040B1 DK175040B1 (da) 2004-05-10

Family

ID=8523472

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198704966A DK175040B1 (da) 1986-11-11 1987-09-22 Anvendelse af medetomidin til fremstilling af lægemiddel til brug ved behandling af angstsygdomme

Country Status (12)

Country Link
US (1) US4783477A (da)
EP (1) EP0270267B1 (da)
JP (1) JPS63135330A (da)
AT (1) ATE88343T1 (da)
AU (1) AU587144B2 (da)
DE (1) DE3785549T2 (da)
DK (1) DK175040B1 (da)
ES (1) ES2054687T3 (da)
FI (1) FI864570A0 (da)
HU (1) HU201472B (da)
IE (1) IE60121B1 (da)
ZA (1) ZA878055B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
GB9111732D0 (en) * 1991-05-31 1991-07-24 Orion Yhtymae Oy The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
GB2256135B (en) 1991-05-31 1995-01-18 Orion Yhtymae Oy Transdermal administration of 4-substituted imidazoles
US5457100A (en) * 1991-12-02 1995-10-10 Daniel; David G. Method for treatment of recurrent paroxysmal neuropsychiatric
NZ504667A (en) * 1997-12-04 2003-03-28 Allergan Sales Inc Substituted imidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
US10780079B2 (en) * 2012-10-15 2020-09-22 Orion Corporation Veterinary method of alleviating noise aversion
TWI645866B (zh) 2013-10-07 2019-01-01 美商帝國製藥美國股份有限公司 右美托咪啶經皮輸送裝置及使用其之方法
RU2648449C2 (ru) 2013-10-07 2018-03-26 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы и композиции для трансдермальной доставки неседативного количества дексмедетомидина
US20150098997A1 (en) * 2013-10-07 2015-04-09 Teikoku Pharma Usa, Inc. Methods and Compositions for Treating Attention Deficit Hyperactivity Disorder, Anxiety and Insomnia Using Dexmedetomidine Transdermal Compositions
PL3554501T3 (pl) * 2016-12-13 2021-12-06 Orion Corporation Deksmedetomidyna lub medetomidyna do zastosowania w leczeniu lęku separacyjnego u zwierząt towarzyszących

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1560271A (en) * 1977-01-14 1980-02-06 Joullie International Sa Therapeutically useful m-trifluoromethylphenylpiperazine derivatives
US4147872A (en) * 1977-09-13 1979-04-03 Pfizer Inc. 3-[2-Hydroxy-4-(substituted)-phenyl]azacycloalkanes and derivatives thereof as analgesic agents and intermediates therefor
ZA815327B (en) * 1980-08-05 1982-07-28 Hoffmann La Roche Benzazepine derivatives
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
US4575510A (en) * 1983-02-17 1986-03-11 Merrell Dow Pharmaceuticals Inc. Method of alleviating withdrawal symptoms
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
NL8500047A (nl) * 1985-01-09 1986-08-01 Philips Nv Televisie ontvanger met teletext-decodeerschakeling en paginanummergeheugen.

Also Published As

Publication number Publication date
EP0270267B1 (en) 1993-04-21
US4783477A (en) 1988-11-08
DK496687A (da) 1988-05-12
DE3785549T2 (de) 1993-09-09
DK175040B1 (da) 2004-05-10
HU201472B (en) 1990-11-28
IE60121B1 (en) 1994-06-01
JPS63135330A (ja) 1988-06-07
DE3785549D1 (de) 1993-05-27
IE873015L (en) 1988-05-11
HUT45399A (en) 1988-07-28
EP0270267A2 (en) 1988-06-08
ZA878055B (en) 1988-04-26
FI864570A0 (fi) 1986-11-11
ES2054687T3 (es) 1994-08-16
EP0270267A3 (en) 1990-07-04
AU587144B2 (en) 1989-08-03
ATE88343T1 (de) 1993-05-15
AU7826987A (en) 1988-05-12

Similar Documents

Publication Publication Date Title
IT8767624A0 (it) Dispositivo per il massaggio manuale del rivestimento cutaneo
IT7950379A0 (it) Procedimento per il trattamento di acque di scarico
DK549189A (da) Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge
DK496687A (da) Anvendelse af medetomidin til fremstilling af laegemiddel til brug ved behandling af angstsygdomme
DK149876C (da) Kobling til styring af driften af tandlaegers behandlingsinstrumenter
ATE158183T1 (de) Arzneimittel zur behandlung von anxietas
FR2565493B1 (fr) Appareil d'electrotherapie, pour le traitement du cuir chevelu
DK472688D0 (da) Anvendelse af bezafibrat til behandling af diabetes
DK253688D0 (da) Laegemiddel til brug ved behandling af atherosclerose
DK298187A (da) Applikator til behandling af laeber
LV10391A (lv) Alkilfosforskabes savienojumu izmantosana psoriazes tipa slimibu arstesanai
NO862454L (no) Fremgangsmaate for behandling av peroxydblekeavluter.
FR2590479B2 (fr) Appareil d'abduction des membres superieurs
FR2585561B1 (fr) Appareil d'abduction des membres superieurs
FR2601955B1 (fr) Procede de preparation d'alkyl et d'arylchlorosilane
BE894776A (fr) Composition sous forme de shampooing a base d'anthraline ou d'un derive pour le traitement des maladies de la peau
NO167677C (no) Fremgangsmaate ved behandling av stoepejernsmelter med magnesium
DE3684825D1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
RO94514A2 (ro) Procedeu pentru tratarea namolurilor
RO92740A2 (ro) Compozitie medicamentoasa pentru tratamentul otitelor
RO92404A2 (ro) Aparat pentru injectarea substantelor de contrast
DE3770133D1 (de) Arzneimittel zur behandlung und prophylaxe von leber- und nierenkrankheiten.
RO91652A2 (ro) Compozitie medicamentoasa pentru tratamentul unor dermatoze
IT8603003V0 (it) Crick martinetto del 2000
NO873220D0 (no) Fremgangsmaate og anlegg for noeytralisering av sur roek utviklet i saerdeleshet ved forbrenning av avfall.

Legal Events

Date Code Title Description
PUP Patent expired